2-47799852-C-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1
The NM_000179.3(MSH6):c.1869C>T(p.Pro623Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000149 in 1,614,156 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000179.3 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000598 AC: 91AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000240 AC: 60AN: 250400Hom.: 1 AF XY: 0.000229 AC XY: 31AN XY: 135646
GnomAD4 exome AF: 0.000102 AC: 149AN: 1461852Hom.: 1 Cov.: 34 AF XY: 0.0000935 AC XY: 68AN XY: 727222
GnomAD4 genome AF: 0.000604 AC: 92AN: 152304Hom.: 0 Cov.: 32 AF XY: 0.000604 AC XY: 45AN XY: 74474
ClinVar
Submissions by phenotype
not specified Benign:4
- -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
- -
- -
Hereditary cancer-predisposing syndrome Benign:4
The synonymous variant NM_000179.3(MSH6):c.1869C>T (p.Pro623=) has been reported to ClinVar as Benign/Likely benign with a status of (2 stars) criteria provided, multiple submitters, no conflicts (Variation ID 182663 as of 2024-08-01). The variant is observed in one or more well-documented healthy adults. The p.Pro623= variant is observed in 10/5,008 (0.1997%) alleles from individuals of 1kG All background in 1kG, which is greater than expected for the disorder. The p.Pro623= variant is not predicted to disrupt an existing splice site. The p.Pro623= variant results in a substitution of a base that is not predicted conserved by GERP++ and PhyloP. For these reasons, this variant has been classified as Benign. -
- -
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
- -
Lynch syndrome 5 Benign:3
This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. -
- -
- -
Hereditary nonpolyposis colorectal neoplasms Benign:1
- -
Malignant tumor of breast Benign:1
The MSH6 p.Pro623= variant was not identified in the literature nor was it identified in the GeneInsight-COGR, Cosmic, MutDB, Insight Colon Cancer Gene Variant Database, Zhejiang Colon Cancer Database, Mismatch Repair Genes Variant Database, Insight Hereditary Tumors Database databases. The variant was identified in dbSNP (ID: rs141242295) “With Likely benign allele”, ClinVar (classified benign by GeneDx, Invitae and likely benign by Ambry Genetics, Counsyl and Quest Diagnostics Nichols Institute San Juan Capistrano), Clinvitae (4x), UMD-LSDB (2x as UV), and in control databases in 77 (1 homozygous) of 276602 chromosomes at a frequency of 0.0003 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). Breakdown of the observations by population include African in 53 (1 homozygous) of 23906 chromosomes (freq: 0.002), Other in 1 of 6460 chromosomes (freq: 0.00002), Latino in 9 of 34400 chromosomes (freq: 0.0003), East Asian in 7 of 18854 chromosomes (freq: 0.0004), and South Asian in 7 of 30774 chromosomes (freq: 0.0002) while not observed in the European Non-Finnish, Ashkenazi Jewish and European Finnish populations. The p.Pro623= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at